Breaking News Instant updates and real-time market news.

AGN

Allergan

$146.39

-3.31 (-2.21%)

16:25
03/25/19
03/25
16:25
03/25/19
16:25

Allergan claims Appaloosa looking to undermine CEO and pushing for firesale

In a regulatory filing, Allergan states: "Allergan's highly engaged, refreshed and independent Board of Directors is focused on doing what is in the best interests of all shareholders. We believe Appaloosa, who owns less than 1% stake, is attempting to undermine our CEO and pushing for a firesale of the company for a short-term bump in stock price. We believe that it will be transparent to investors that Appaloosa's short-term interests are not the same as those of long-term shareholders."

  • 25

    Mar

  • 18

    May

AGN Allergan
$146.39

-3.31 (-2.21%)

03/19/19
RHCO
03/19/19
INITIATION
Target $178
RHCO
Buy
Allergan initiated with a Buy at SunTrust
SunTrust analyst Gregg Gilbert initiated Allegran with a Buy rating and a price target of $178. The analyst states that while the stock has been underperforming, he also sees it as inexpensive with valuation reflecting competitive threats to franchises. Gilbert believes that Allergan offers an "attractive return potential over the next 12+ months if the company continues to meet or exceed its financial targets".
03/19/19
RHCO
03/19/19
INITIATION
Target $29
RHCO
Buy
Evolus assumed with a Buy at SunTrust
SunTrust transferred coverage of Evolus (EOLS) to analyst Gregg Gilbert, who established a Buy rating and $29 price target on the stock. The analyst cites the company preparing to enter the US botulinum toxin market, adding that with Jeuveau "de-risked from a regulatory standpoint following FDA approval", investor focus will shift to the near-term launch of "frictionless alternative" to market-leading Botox from Allergan (AGN). Gilbert contends that Evolus could carve a "nice slice of this rapidly-growing market".
03/20/19
PIPR
03/20/19
NO CHANGE
Target $161
PIPR
Neutral
Piper Jaffray questions value creation of potential Allergan break up
There is some thought among investors that a separation of Allergan (AGN) into its global medical aesthetics business and its pharma business should unlock significant value, Piper Jaffray analyst David Amsellem tells investors in a research note titled "A Break Up Is By No Means A Panacea; Staying Cautious." The analyst's questions this thinking, saying this course of action "cannot paper over the challenges" facing both businesses. His sum-of-the-parts analyses suggest that a break-up "would confer only modest value creation." And even that may not be sustainable as competitive challenges surrounding Botox and losses of exclusivities beyond Restasis come into focus, contends Amsellem. "Simply put, a separation in and of itself is not the transformative change we would be looking for," says the analyst. He reiterates a Neutral rating on Allergan with a $161 price target.
03/22/19
ADAM
03/22/19
NO CHANGE
ADAM
Buy
Breast implant panel documents in-line with expectations, says Canaccord
Canaccord analyst Kyle Rose maintains his Buy rating on Sientra (SIEN) following the release of briefing documents ahead of next week's FDA panel meeting to review a range of topics related to the long-term benefits and risks of breast implants, stating that the documents appear to be in-line with expectations and do not appear to raise any materially new or concerning questions or data. However, given the warning letters sent this week to Sientra and J&J's (JNJ) Mentor unit, Rose said he expects the FDA to "take a strong tone" during the panel about the responsibility to support the collection and analysis of relevant safety and efficacy clinical data. Other makers of breast implants include Allergan (AGN) and Establishment Labs (ESTA).

TODAY'S FREE FLY STORIES

ABR

Arbor Realty

$14.78

(0.00%)

19:20
12/09/19
12/09
19:20
12/09/19
19:20
Syndicate
Arbor Realty 6.5M share Spot Secondary priced at $14.14 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

STRM

Streamline Health

$1.25

-0.04 (-3.10%)

18:59
12/09/19
12/09
18:59
12/09/19
18:59
Hot Stocks
Streamline Health delaying Q3 results to resolve amortization charge »

Streamline Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

NLOK

NortonLifeLock

$25.43

-0.02 (-0.08%)

, INTC

Intel

$56.52

-0.28 (-0.49%)

18:55
12/09/19
12/09
18:55
12/09/19
18:55
Periodicals
McAfee weighs combination with NortonLifeLock, WSJ reports »

NortonLifeLock (NLOK) has…

NLOK

NortonLifeLock

$25.43

-0.02 (-0.08%)

INTC

Intel

$56.52

-0.28 (-0.49%)

AVGO

Broadcom

$314.49

-1.68 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

  • 19

    Dec

  • 23

    Jan

TGTX

TG Therapeutics

$9.28

2.17 (30.52%)

18:55
12/09/19
12/09
18:55
12/09/19
18:55
Conference/Events
TG Therapeutics to host investor & analyst meeting »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

NTNX

Nutanix

$33.87

-0.725 (-2.10%)

18:41
12/09/19
12/09
18:41
12/09/19
18:41
Hot Stocks
Nutanix CEO: We are transitioning to a subscription-based model »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 13

    Dec

  • 16

    Dec

SFIX

Stitch Fix

$25.17

1.04 (4.31%)

, MDB

MongoDB

$131.03

-0.19 (-0.14%)

18:33
12/09/19
12/09
18:33
12/09/19
18:33
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Stitch…

SFIX

Stitch Fix

$25.17

1.04 (4.31%)

MDB

MongoDB

$131.03

-0.19 (-0.14%)

PHR

Phreesia

$29.01

-0.09 (-0.31%)

CDMO

Avid Bioservices

$5.85

0.05 (0.86%)

MTN

Vail Resorts

$231.30

-1.43 (-0.61%)

TOL

Toll Brothers

$41.40

0.515 (1.26%)

EQ

Equillium

$4.00

-0.03 (-0.74%)

SUPN

Supernus

$22.69

-0.145 (-0.63%)

A

Agilent

$81.68

-0.545 (-0.66%)

HEPA

Hepion Pharmaceuticals

$5.61

0.4 (7.68%)

ROAD

Construction Partners

$20.56

0.66 (3.32%)

CASY

Casey's General Stores

$175.33

-0.47 (-0.27%)

CHWY

Chewy

$24.17

-0.76 (-3.05%)

LVGO

Livongo Health

$27.40

-0.6 (-2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 11

    Dec

  • 12

    Dec

  • 18

    Dec

  • 19

    Dec

BLUE

Bluebird Bio

$76.72

-2.79 (-3.51%)

, BMY

Bristol-Myers

$61.32

1.38 (2.30%)

18:24
12/09/19
12/09
18:24
12/09/19
18:24
Hot Stocks
Bluebird Bio, Bristol-Myers present update on Phase 1 study of bb21217 »

Bluebird bio (BLUE) and…

BLUE

Bluebird Bio

$76.72

-2.79 (-3.51%)

BMY

Bristol-Myers

$61.32

1.38 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

BA

Boeing

$351.25

-2.74 (-0.77%)

18:22
12/09/19
12/09
18:22
12/09/19
18:22
Periodicals
Former Boeing employee Pierson to testify at U.S. House hearing, Reuters says »

An ex-Boeing employee who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

OXY

Occidental Petroleum

$37.34

-0.07 (-0.19%)

18:21
12/09/19
12/09
18:21
12/09/19
18:21
Hot Stocks
Occidental Petroleum director buys 12.9K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

OXY

Occidental Petroleum

$37.34

-0.07 (-0.19%)

18:14
12/09/19
12/09
18:14
12/09/19
18:14
Hot Stocks
Occidental Petroleum director buys 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

EDIT

Editas Medicine

$30.34

-0.6 (-1.94%)

18:02
12/09/19
12/09
18:02
12/09/19
18:02
Hot Stocks
Editas Medicine announces in vivo proof-of-concept data for EDIT-301 »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSB

Mesabi Trust

$23.93

0.71 (3.06%)

, CLF

Cleveland-Cliffs

$8.52

0.38 (4.67%)

17:56
12/09/19
12/09
17:56
12/09/19
17:56
Hot Stocks
Mesabi Trust initiates arbitration against Northshore Mining, Cleveland-Cliffs »

The Trustees of Mesabi…

MSB

Mesabi Trust

$23.93

0.71 (3.06%)

CLF

Cleveland-Cliffs

$8.52

0.38 (4.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFBC

First Financial Bancorp

$24.67

0.12 (0.49%)

17:51
12/09/19
12/09
17:51
12/09/19
17:51
Hot Stocks
First Financial Bancorp chairman Davis sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRE

Green Plains

$14.26

-0.49 (-3.32%)

17:47
12/09/19
12/09
17:47
12/09/19
17:47
Hot Stocks
Green Plains CEO Todd Becker sold over 607K in company shares »

Green Plains CEO Todd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$111.12

-2.02 (-1.79%)

17:43
12/09/19
12/09
17:43
12/09/19
17:43
Hot Stocks
Medtronic director buys 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

VAC

Marriott Vacations

$123.77

-0.1 (-0.08%)

17:41
12/09/19
12/09
17:41
12/09/19
17:41
Hot Stocks
Marriott Vacations raises quarterly dividend to 54c from 45c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSLY

Fastly

$20.82

-0.35 (-1.65%)

17:36
12/09/19
12/09
17:36
12/09/19
17:36
Hot Stocks
Fastly director Sunil Dhaliwal sells almost $576K in company shares »

Fastly director Sunil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

SFIX

Stitch Fix

$25.17

1.04 (4.31%)

17:36
12/09/19
12/09
17:36
12/09/19
17:36
Hot Stocks
Stitch Fix says saw healthy growth in both women's, men's categories »

Says shows online…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

  • 12

    Dec

  • 19

    Dec

F

Ford

$9.00

-0.015 (-0.17%)

17:32
12/09/19
12/09
17:32
12/09/19
17:32
Hot Stocks
Ford expects to roughly halve 2018 China EBIT loss »

During a meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 07

    Jan

  • 04

    Feb

VEEV

Veeva

$143.56

-1.115 (-0.77%)

17:28
12/09/19
12/09
17:28
12/09/19
17:28
Hot Stocks
Veeva CMO sells 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BLDR

Builders FirstSource

$25.71

0.45 (1.78%)

17:25
12/09/19
12/09
17:25
12/09/19
17:25
Hot Stocks
Builders FirstSource acquires assets of Raney Components, Construction »

Builders FirstSource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

S

Sprint

$5.40

-0.145 (-2.62%)

, TMUS

T-Mobile

$75.90

-1.87 (-2.40%)

17:16
12/09/19
12/09
17:16
12/09/19
17:16
Periodicals
Judge seeks speedy trial over T-Mobile, Sprint deal, WSJ reports »

U.S. District Judge…

S

Sprint

$5.40

-0.145 (-2.62%)

TMUS

T-Mobile

$75.90

-1.87 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 16

    Dec

WEN

Wendy's

$21.72

0.15 (0.70%)

17:15
12/09/19
12/09
17:15
12/09/19
17:15
Hot Stocks
Wendy's sees FY20 FCF of $210M-$220M including impact of settlement »

As a result of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BANX

StoneCastle

$22.99

0.25 (1.10%)

17:15
12/09/19
12/09
17:15
12/09/19
17:15
Hot Stocks
Breaking Hot Stocks news story on StoneCastle »

StoneCastle trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIZ

Assurant

$130.91

-0.66 (-0.50%)

17:14
12/09/19
12/09
17:14
12/09/19
17:14
Hot Stocks
Assurant director sells 21.8K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.